Advertisement

Topics

Latest Biotechnology NewsRSS

14:29 EDT 20th September 2017 | BioPortfolio

ROTH Capital Partners Announces the Addition of Jotin Marango, M.D., Ph.D. and Yasmeen Rahimi, Ph.D. to its Healthcare Research Team

ROTH Capital Partners (“ROTH”), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, today announced that Jotin Marango, M.D., Ph.D. and Yasmeen Rahimi, Ph.D. have joined the firm’s healthcare research team. Dr. Marango is a Managing Director and Senior Research Analyst covering ...

F-Prime Capital Announces Joshua Grass as New Entrepreneur-in-Residence

F-Prime Capital, a global venture capital firm focused on investments in healthcare and technology, today announced that Joshua Grass has joined the firm as entrepreneur-in-residence. Mr. Grass will primarily focus on advancing life sciences company-creation activities at F-Prime. “We are excited to welcome Josh to the firm and believe he will be an ...

BioTime to Present at the Ladenburg Thalmann 2017 Healthcare Conference

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that Adi Mohanty, Co-Chief Executive Officer, and Russell Skibsted, Chief Financial Officer, will present at the Ladenburg Thalmann 2017 Healthcare Conference in New York. Mr. Mohant...

BioTime to Present at the Cantor Fitzgerald Global Healthcare Conference

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that Adi Mohanty, Co-Chief Executive Officer, and Russell Skibsted, Chief Financial Officer, will present at the Cantor Fitzgerald Global Healthcare Conference in New York. Mr. Mohan...

Ignyta to Present at Cantor Fitzgerald 2017 Global Healthcare Conference

Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make a presentation at the Cantor Fitzgerald 2017 Global Healthcare Conference on Wednesday, September 27, 2017, at 1:05 p.m. Eastern time (10:05 a.m. Pacific time) in New York, NY. ...

Aldeyra Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference

LEXINGTON, Mass., Sept. 20, 2017 /PRNewswire/ -- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of metabolism, and other diseases related to endogenous aldehyde toxicity, today announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will present at the Annual Cantor Fitzgerald Global H...

Generex Biotechnology Corporation Announces New Clinical Trial Of Hema Diagnostic Systems??? Rapid 1-2-3 Tuberculosis Point-Of-Care Tests

  Life Sciences Jobs   ...

Revance to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in aesthetic and therapeutic indications, today announced that the company will participate in the Cantor Fitzgerald 2017 Global Healthcare Conference in New York, NY. Revance management is scheduled to present on Tuesday, September 26 at ...

Minerva Biotechnologies Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryMinerva Biotechnologies Corp Minerva is a biotechnology company that develops immunotherapies and cancer drugs. The company offers antibody for Tcell immunotherapy, which is used in advanced breast and ovarian cancers; and humanized antibodies used for prostate and breast cancer. It offers antimetastasis antibody that block the metastatic growth factor and transition from a regular cancer c...

Taiga Biotechnologies Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryTaiga Biotechnologies Inc Taiga Biotech is a biopharmaceutical company that develops protein and cellular therapies. The company develops therapies for diseases including cancers and infectious diseases. Its pipeline products include programs such as stem cell therapy and target specific Tcells. Taiga Biotech's programs are developed for diseases including HIV and influenza, and hematologic...

Synthace Raises £7.3m to Accelerate Biotechnology to Enable Faster Breakthroughs

The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development Speaking from the World Economic Forum, Sustainable Development Impact Summit, CEO Tim Fell stresses the need to make biology a true engineering discipline Funding t...

Markets—not morals—prompt former GMO executives move to anti-biotechnology labs

Enlivex Therapeutics Announces Closing of USD 8 Million Series B Round Led by KOREA INVESTMENT PARTNERS (KIP) and HADASIT BIO HOLDINGINGS LTD. (HBL)

JERUSALEM, September 19, 2017 /PRNewswire/ -- Enlivex Therapeutics Ltd., a clinical stage immunotherapy company, announced today the closing of an $8 million equity financing round at a valuation of approximately $50 Million pre-closing. Korea Investment Partners (KIP) has invested USD 6 million in the financing round, and Hadasit Bio Holdingings Ltd. (HBL) (TASE:HDST) has co-invested USD ...

PureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology for Oral Administration of Biologics, Nucleic Acids, and Complex Small Molecules

PureTech Health plc (“PureTech Health” or the “Company”, LSE: PRTC), an advanced, clinical-stage biopharmaceutical company, today announced an exclusive licensing agreement with 3P Biotechnologies, Inc., via University of Louisville, for an exosome-based technology (Calix) for the oral administration of biologics, nucleic acids, and complex small m...

Synthace Ltd Raises ??7.3 Million To Accelerate Biotechnology To Enable Faster Breakthroughs

  Life Sciences Jobs   ...

Athera Biotechnologies Concludes Follow-Up Visits In Multiple Dosing Trial With Its Immunovascular Antibody

  Life Sciences Jobs   ...

#jobs #lifescience Operations/Office Manager Wanted at Start-up!

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Operations/Office Manager Wanted at Start-up! .MA-Cambridge, Our client, a Cambridge-based Biotechnology firm, is looking for the first operational/administrative hire! The company is in start-up mode and is funded … Continue reading → Cet article #jobs #lifescienc...

Puma Biotechnology to Present at Cantor Fitzgerald Healthcare Conference

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company, including recent developments, at 1:40 p.m. EDT on Tuesday, September 26, at the Cantor Fitzgerald Global Healthcare Conference. The conference will...

Heron Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference

Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to address some of the most important unmet patient needs, announced that Barry D. Quart, Pharm.D., Chief Executive Officer of Heron Therapeutics, will present at the Cantor Fitzgerald Global Healthcare Conference on Monda...

GMO Answers Launches Online Video Contest

WASHINGTON, Sept. 18, 2017 /PRNewswire-USNewswire/ -- GMO Answers today previews its annual "Get to Know GMOs Month" with the launch of an online video submission contest. The GMO Innovation Contest is designed to encourage anyone to "Get to Know GMOs" by showcasing real-world problems facing our food supply and food production system that could be solved using GMOs and biotechnology though an int...

FDA Clears Biotech Drug Copycats, But Buying Them Isn't So Easy 2 hours ago

In 2016, Roche Holding AG sold $3 billion worth of its blockbuster biotechnology drug Avastin. Last week, the U.S. Food and Drug Administration approved what's expected to be a less-expensive version.

Ignyta to Present at the Ladenburg Thalmann 2017 Healthcare Conference

Ignyta, Inc. (Nasdaq:RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jonathan Lim, M.D., its Chairman and Chief Executive Officer, will make a presentation at the Ladenburg Thalmann 2017 Healthcare Conference on Tuesday, September 26, 2017, at 2:00 p.m. Eastern time (11:00 a.m. Pacific time) in New York, NY. ...

AmpliPhi Biosciences’ CEO to Moderate Panel Discussion at Upcoming Anti-Infectives Rx Conference

AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of therapies for antibiotic-resistant infections using bacteriophage technology, announces that CEO Paul C. Grint, M.D., will moderate a panel titled, “Advances Against Rare and Resistant Pathogens” at the Anti-Infectives Rx Confere...

TriLink BioTechnologies Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryTriLink BioTechnologies Inc TriLink, a subsidiary of Maravai Life Sciences Inc is a manufacturer of modified nucleic acid products. The company's products include oligonucleotides, nucleotides, custom chemistry, DNA synthesis reagents, cleanamp PCR products, mRNA and long RNA, among others. It also provides contract research and modified compounds such as aminoallyl, biotin, and two fluoro ...

#news #biotech CHMP candidate check

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CHMP candidate check . from European Biotechnology – first and foremost in European biotech http://ift.tt/2xdN8hs Cet article #news #biotech CHMP candidate check est apparu en premier sur Biotech 365.

Quick Search
Advertisement
 

review and buy Biotechnology market research data and corporate reports here